APA

Fan R., Sun J., Yuan Q., Xie Q., Bai X., Ning Q., Cheng J., Yu Y., Niu J., Shi G., Wang H., Tan D., Wan M., Chen S., Xu M., Chen X., Tang H., Sheng J., Lu F., Jia J., Zhuang H., Xia N. & Hou J. (20160509). Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. : Gut.

Chicago

Fan Rong, Sun Jian, Yuan Quan, Xie Qing, Bai Xuefan, Ning Qin, Cheng Jun, Yu Yanyan, Niu Junqi, Shi Guangfeng, Wang Hao, Tan Deming, Wan Mobin, Chen Shijun, Xu Min, Chen Xinyue, Tang Hong, Sheng Jifang, Lu Fengmin, Jia Jidong, Zhuang Hui, Xia Ningshao and Hou Jinlin. 20160509. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. : Gut.

Harvard

Fan R., Sun J., Yuan Q., Xie Q., Bai X., Ning Q., Cheng J., Yu Y., Niu J., Shi G., Wang H., Tan D., Wan M., Chen S., Xu M., Chen X., Tang H., Sheng J., Lu F., Jia J., Zhuang H., Xia N. and Hou J. (20160509). Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. : Gut.

MLA

Fan Rong, Sun Jian, Yuan Quan, Xie Qing, Bai Xuefan, Ning Qin, Cheng Jun, Yu Yanyan, Niu Junqi, Shi Guangfeng, Wang Hao, Tan Deming, Wan Mobin, Chen Shijun, Xu Min, Chen Xinyue, Tang Hong, Sheng Jifang, Lu Fengmin, Jia Jidong, Zhuang Hui, Xia Ningshao and Hou Jinlin. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. : Gut. 20160509.